Floatz logo

Huazhi Rougan Granule

Helicobacter Pylori Infection, Susceptibility To

Nanjing First Hospital, Nanjing Medical UniversityN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

1 Active assets in the Helicobacter Pylori Infection, Susceptibility To cohort.

Asset / SponsorPhaseRating
BISMUTH SALICYLATE
Fatih Sultan Mehmet Training and Research Hospital
Phase 4BB
Orelabrutinib
Fudan University
Phase 2CCC

Same molecule, other indications

Huazhi Rougan Granule is also rated in:

Efficacy and SafetyDormant
BB
Indicative ·
68 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
D
Indicative ·
30 / 100
View asset →
liver disorderDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →